Save the Date!

Location: Warsaw

Date: Friday, September 20, 2024

The primary objective of the  Investigator Brochure (IB) in a Phase 1 trial is to serve the responsible investigator for reliable benefit-risk assessment, however experience teaches us that it is mostly viewed and written as a Clinical Trial Authorisation document.

Help us to create a more meaningful IB process for translational results’ interpretation, investigator-centred presentation and decision-making.

Block your agenda for this interactive EUFEMED workshop in Warsaw on 20 September 2024!